The American Society for Transplantation and Cellular Therapy (ASTCT) and EBMT are proud to announce the Inaugural 2021 Joint ASTCT-EBMT Basic and Translational Scientific Retreat, taking place October 13 – 15, 2021.
The Basic and Translational Scientific Retreat will be a 2.5-day conference focused on cutting edge basic and translational biology in the field. The meeting will focus on fundamental themes and novel technologies with an emphasis on unpublished and innovative science. Attendance to the meeting will be limited to 100 attendees with afternoon breaks to allow for informal networking opportunities between junior and senior attendees. The meeting will host two days of poster sessions and a best oral abstract session.
The program is intended for both junior and senior members of the blood and marrow transplantation and cellular therapy field.
Please click the document above to download the preliminary Scientific Programme
Joint ASTCT – EBMT Basic and Translational Scientific Retreat
October 13 – October 15, 2021
Vail Marriott Mountain Resort
Vail, Colorado, United States
HEALTH & SAFETY:
ASTCT and EBMT are continuing to monitor recommendations from the CDC and WHO. Updates regarding the feasibility of an in-person event will be provided in the coming months. For COVID-19 updates and what to expect at the Vail Marriott Mountain Resort, please visit: https://whattoexpect.marriott.com/whrco
Face coverings will be required in all indoor public areas.
Registration to this event is limited to a maximum of 100 total attendees. We are unable to accept additional registrants once the registration capacity has been met.
Registration will open in mid-May.
Junior Attendee Rate*
Senior Attendee Rate
*Junior attendees are defined as post doctoral fellows, current fellows, and junior faculty within the first three years of appointment.
The 2021 Joint ASTCT-EBMT Basic and Translational Scientific Retreat will be accepting abstract data/research highlighting the best of basic and translational science. Click here to submit your abstract by Friday, April 30 at 5:00 p.m. CT. Notices regarding abstract submissions will be made available in mid-May.
Lead Investigator(s) for accepted abstracts are required to register for the retreat upon notification of acceptance. Any abstract whose investigator(s) do not register in a timely manner will have their acceptance retracted.
The 2021 Joint ASTCT-EBMT Basic and Translational Scientific Retreat will be accepting abstract data/research highlighting the best of basic and translational science.
Click here to submit your abstract by Friday, April 30 at 5:00 p.m. CT. Notices regarding abstract submissions will be made available in mid-May.
Abstract Submission Criteria
Abstracts will be scored based on the following criteria:
- Importance and Relevance: Is a clear rationale for the work provided? Does the study address an important question? Do its findings have the potential to advance the field of blood and marrow or cellular therapies?
- Originality and Innovation: Is the work novel? Does it present new findings and/or address a problem using an original or improved approach?
- Quality of Methods and Writing: Are methods well described and valid to answer the question? Is the abstract clear and well written? Is the abstract within the 300-word limit?
- Please note that the abstract submission form does not have a tracker for word count. We recommend that you prepare your abstract submission in a Word document to confirm that you stay within the 300-word limit.
The top-scoring abstracts will be selected as Oral Platform Presentations; top-scoring abstracts that are not selected for Oral Platforms will be selected as Distinguished Posters.
Responsibility of Abstract Authors
The Presenting Author is responsible for the following:
- Ensuring that all authors have read the abstract and agreed to be co-authors.
- Notifying all co-authors of any additions, deletions, and changes to the program, as may be communicated by the Joint ASTCT-EBMT Basic and Translational Scientific Retreats.
- Obtaining all of the conflict-of-interest disclosure information from co-authors.
Making certain that abstracts are complete (tables included and labeled) and written in clear, concise and grammatically correct English, so that reviewers are able to focus solely on the scientific merits of the submission. For authors with any questions regarding the clarity, grammar or spelling of their abstract, we encourage identifying and using an independent reviewer to edit the abstract prior to submission.
If you are interested in sponsoring this event, please contact Angie Dahl